ライフサイエンスコーパス: disease

1 Disease progression includes composite mortality, hospitaliza

2 sence of bursitis in more than half of patients with active disease.

3 sed estimates suggest the prevalence of pediatric and adult disease may be similar.

4 surement of distal lung ventilation reflecting small-airway disease.

5 n-6 PUFA levels in colostrum and breast milk with allergic disease and lung function at ages 12 and 18 years.

6 on Health and Science University Layton Aging and Alzheimer Disease Center and Oregon Brain Bank.

7 nital and childhood glaucomas have strong genetic bases and disease-causing mutations have been discovered in several gen

8 d age (>67) was the strongest predictor of overall (OS) and disease free survival (DFS) (p = 0.00001; p = 0.01, respectiv

9 y diseases, such as allergy, asthma, and inflammatory bowel disease.

10 Data suggest that the prediction of adult cardiovascular disease using a model comprised entirely of adult nonlaborato

11 They also had significantly higher rates of cardiovascular disease and hypotension.

12 Although often described as a childhood disease, newer population-based estimates suggest the prevale

13 here are negative mortality dose trends for all circulatory disease (p = 0.014) and ischaemic heart disease (p = 0.003),

14 arlier findings and strengthen the evidence for circulatory-disease mortality radiation risk at doses <0.5 Gy.

15 oarthropathy (n = 15), and calcium pyrophosphate deposition disease (CPPD) (n = 15), from the Hamann-Todd collection of h

16 states and two cities participating in the U.S. Centers for Disease Control and Prevention (CDC)'s Climate-Ready States a

17 sks of disease-related outcomes and 5-year recurrence-free, disease-specific, and overall survival.

18 maternal GBS colonization, (2) cases of infant invasive GBS disease, (3) deaths, and (4) disabilities.

19 processes may improve clinical management and public health disease control.

20 for all circulatory disease (p = 0.014) and ischaemic heart disease (p = 0.003), possibly due to competing causes of deat

21 zations, whereas 172 suffered from a chronic ischemic heart disease (CIHD), 126 of whom underwent challenges.

22 During human immunodeficiency virus (HIV) disease, chronic immune activation leads to T-cell exhaustion

23 ciated with various genetic disorders (e.g., the Huntington disease), and thus was used in genetic testing for screening

24 f genomic/genetic variation that plays an important role in disease susceptibility.

25 as a model organism Ceratonova shasta, which causes lethal disease in salmonids.

26 ity following recurrence included model for end-stage liver disease at LT >23, time to recurrence, >3 recurrent nodules,

27 (22%), SCA6 (14%), EA2 (13%), SPG7 (10%) and mitochondrial disease (10%).

28 del antibiotic and Helicobacter pylori infection as a model disease.

29 ct, none of the available drugs has shown clear evidence of disease-modifying activity, even if some patients treated wit

30 Risks of disease-related outcomes and 5-year recurrence-free, disease-

31 XCR2 antagonists to inhibit or prevent metastatic spread of disease.

32 Prion diseases, like Alzheimer's disease and Parkinson disease, are rapidly progressive neurodegenerative disorders

33 treatment of levodopa-induced dyskinesia (LID) in Parkinson disease (PD) is an unmet need.

34 shed recommendations on the medical management of Parkinson disease (PD) during Ramadan.

35 Alveolar rhabdomyosarcoma (ARMS) is a devastating pediatric disease driven by expression of the oncogenic fusion gene PAX

36 Purpose Minimal residual disease (MRD) and genetic abnormalities are important risk fa

37 Alzheimer's disease (AD; n = 164) was identified with 70% sensitivity and

38 Prion diseases, like Alzheimer's disease and Parkinson disease, are rapidly progressive neurod

39 Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are complex chronic

40 ) using data from nine cohorts of patients with Parkinson's disease from North America and Europe assessed between 1986 a

41 was documented, 45 (48.4%) were diagnosed with early-stage disease (American Joint Committee on Cancer [AJCC] stage 0, I

42 0, I, or II), and 48 (51.6%) were diagnosed with late-stage disease (AJCC stage III or IV).

43 y not need or want palliative care involvement early in the disease trajectory.

44 potentially help to elucidate the complex mechanisms of the disease and lead to the development of more effective individ

45 gene have been linked to differential susceptibility to the disease in many species.

46 Understanding and treating this disease remains a challenge, as seizures manifest through mec

47 ls are essential to skin health and can potentially lead to disease when their abundances and activities change due to al

48 women infected with chlamydiae develop upper genital tract disease, but the reason(s) for this remains undefined.

49 lation, in association with the treatment of the underlying disease, represents a valid approach that can improve the pul

50 itting MS (RRMS) or clinically isolated syndrome (CIS) with disease onset before 18 years of age and duration of less tha